JNJ-75276617

MD Anderson researchers investigated the gut microbiome, lung adenocarcinoma genesis, and tested new therapies. Highlights include a bean diet improving gut microbiome balance, durvalumab and olaparib reducing endometrial cancer risk, novel leukemia therapies, IL-17 research, ELI-002 vaccine for KRAS-mutated cancers, a lung cancer pre-cancer atlas, saruparib for breast cancer, nivolumab reducing lung cancer relapse, proton therapy for head and neck cancer, GPX4 co-inhibition overcoming PARP resistance, and CD28 costimulation enhancing CAR NK cell efficacy.